跳至主要内容
临床试验/RBR-249zxxh
RBR-249zxxh尚未招募1 期

Development and evaluation of a topical formulation containing jucá product(Libidibia ferrea) for the treatment of cutaneous Leishmaniasis

niversidade Federal do Amazonas - UFAM0 个研究点开始时间: 2022年9月19日最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Intervention

入排标准

年龄范围
18Y 至 70Y(—)

入选标准

  • Age between 18 and 70 years; both genders; Individuals considered healthy after initial clinical and laboratory evaluation; Agreement and voluntary signature of the free and informed consent form

排除标准

  • Individuals who present alterations in the pre-treatment clinical and/or laboratory assessment; History of visceral leishmaniasis or American cutaneous leishmaniasis; Liver or kidney dysfunction, diabetes or heart disease; Allergy to the experimental treatment; Pregnant and lactating women; Alcoholics, smokers or those using medication; Patients with chronic diseases and/or infectious diseases such as tuberculosis, leprosy, human immunodeficiency virus, visceral leishmaniasis or American cutaneous leishmaniasis, among others; Patients with a medical history of visceral leishmaniasis or American cutaneous leishmaniasis; Inability or refusal to sign the informed consent form or inability to comply with the experimental protocol

研究者

发起方
niversidade Federal do Amazonas - UFAM

相似试验